100% Quality Guarantee
PhD-Level Technical Support
Key Features

Recombinant FGL1 Monoclonal Antibody (AGEL6847)

SKU AGEL6847
Product Type Antibody
Reactivity Human
Applications WB, IHC-P, FC, IP
Host Species Rabbit
Clonality Monoclonal
Clone C321542
Conjugate Unconjugated
$606 - $843

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Recombinant FGL1 Monoclonal Antibody

The Recombinant FGL1 Monoclonal Antibody is a recombinant rabbit monoclonal antibody (clone C321542) against FGL1. Fibrinogen-like protein 1 (FGL1), also known as hepassocin, is a secreted protein mainly expressed in liver and its expression is further enhanced following acute liver injury. FGL1 null mice have multiple metabolic abnormalities and are more prone to develop hepatocellular carcinoma under certain experimental conditions, suggesting FGL1 has diverse functions in vivo. More recently, FGL1 was found to be highly expressed in human cancer cells and function as an inhibitory ligand for LAG3. Produced by recombinant technology in Rabbit hosts and purified by Protein A affinity chromatography, this Rabbit IgG antibody is reactive against Human samples.

This antibody is suitable for WB, IHC-P, FC and IP applications. It has been validated by WB analysis of HepG2, Huh1. The target is localized to the secreted.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose